U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. Drug Databases
  3. Drug Shortages

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Lorazepam Injection
Status: Currently in Shortage
»Date first posted: 05/03/2018
»Therapeutic Categories: Neurology

Expand all

Amphastar Pharmaceuticals, Inc. (Reverified 10/17/2025)

Company Contact Information:
800-423-4136

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Lorazepam, Injection, 2 mg/1 mL (NDC 76329-8261-1) Limited Availability Limited Availability Demand increase for the drug

Fresenius Kabi USA, LLC (Revised 11/05/2025)

Company Contact Information:
888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Lorazepam, Injection, 2 mg/1 mL (NDC 65219-368-02) Unavailable Next release November 2025. Check wholesalers for inventory. Demand increase for the drug

Hikma Pharmaceuticals USA, Inc. (Revised 10/24/2025)

Company Contact Information:
800-631-2174

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Ativan, Injection, 2 mg/1 mL (NDC 0641-6001-25) Limited Availability Lots are being manufactured to meet demand Demand increase for the drug
Ativan, Injection, 2 mg/1 mL (NDC 0641-6000-10) Unavailable Unavailable Regulatory delay
Ativan, Injection, 4 mg/1 mL (NDC 0641-6003-25) Unavailable Unavailable Regulatory delay
Ativan, Injection, 4 mg/1 mL (NDC 0641-6002-10) Unavailable Unavailable Regulatory delay
Lorazepam, Injection, 2 mg/1 mL (NDC 0641-6044-25) Limited Availability Lots are being manufactured to meet demand Demand increase for the drug
Lorazepam, Injection, 2 mg/1 mL (NDC 0641-6046-10) Unavailable Unavailable Regulatory delay
Lorazepam, Injection, 4 mg/1 mL (NDC 0641-6045-25) Unavailable Unavailable Regulatory delay
Lorazepam, Injection, 4 mg/1 mL (NDC 0641-6047-10) Unavailable Unavailable Regulatory delay

Hospira, Inc., a Pfizer Company (Revised 10/23/2025)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Lorazepam, Injection, 2 mg/1 mL Syringes (NDC 0409-1985-30) Unavailable Next Delivery: November 2025; Estimated Recovery: December 2025 Demand increase for the drug
Back to Top